Protein kinase B

Dec 10, 2019

Caris Life Sciences to Present Data Evaluating PI3K Pathway Alterations at the 2019 San Antonio Breast Cancer Symposium (SABCS)

Nov 13, 2019

Today's New Way to Fight Cancer Focusing on Metabolic Therapies

Jul 12, 2019

Zydelig (idelalisib; Gilead) Drug Overview 2019: An Oral, Highly Selective Inhibitor of the Phosphoinositide 3-Kinase (PI3K) Isoform p110-delta

May 22, 2019

Ascentage Pharma to Present New Data at 2019 ASCO Annual Meeting from Clinical Trials of MDM2-p53 Antagonist and IAP Inhibitor in Cancers

Mar 25, 2019

Ascentage Pharma Announces Nine Abstracts To Be Presented at the 2019 American Association for Cancer Research Annual Meeting

Jan 06, 2019

Ascentage Pharma and MD Anderson Cancer Center Announce Strategic Alliance in Cancer Drug Development

May 30, 2018

Chrysanthy Tsakopoulos Demos Named President & CEO Of AKT Investments Inc., Northern California's Largest Land Development Company

May 21, 2018

Ascentage Pharma Announces Promising Phase 1 Interim Results in Two Clinical Programs to Be Presented at 2018 ASCO Annual Meeting

Apr 12, 2018

Ascentage Pharma Announces Five Abstracts To Be Presented at the 2018 American Association for Cancer Research Annual Meeting

Dec 13, 2017

AbilityPharma Announces FDA Approval of IND for Phase 2 Trial of ABTL0812 in Patients with Endometrial Cancer or Squamous Non-Small Cell Lung Cancer

Aug 22, 2017

GDC-0084 Progress Update: On Track for Phase II Commencement in 2017